Company intelligence / Profile preview

Smartfish

Ownership: Private
Development stage: Other

Overview

Smartfish has developed clinically proven nutritional drinks using proprietary emulsion technology, focusing on high omega‑3 content. Their products are used in medical nutrition for chronic disease management, including cancer cachexia, and have shown positive results in improving cardiovascular health parameters. The company is also expanding into sports nutrition with a new line of post-workout recovery drinks. Several clinical studies are ongoing or completed, supporting efficacy claims.

Therapeutic areas: ImmunologyCardiovascularOncology
Modalities: Nutritional productEmulsion-based omega-3 therapyProtein supplement (for sports nutrition)
Industry: Food & Nutrition

Partnerships

Collaboration with elite athletes Jakob, Filip & Henrik Ingebrigtsen for sports line launch

Beyond the preview

Go deeper on Smartfish.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Smartfish.

Explore the full profile